Affymetrix Newswire

Affymetrix Newswire

Comprehensive Real-Time News Feed for Affymetrix.

Results 1 - 15 of 15 in Affymetrix

  1. Critical Comparison: VermillionRead the original story w/Photo

    Friday Jul 21 | IntersportsWire

    Vermillion and Affymetrix are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitabiliy. 36.5% of Vermillion shares are owned by institutional investors.

    Comment?

  2. Very Positive Press Coverage Unlikely to Impact Affymetrix (AFFX) Stock PriceRead the original story w/Photo

    Wednesday Jul 19 | IntersportsWire

    News coverage about Affymetrix has trended very positive on Wednesday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources.

    Comment?

  3. Head-To-Head Contrast: Digiliti MoneyRead the original story w/Photo

    Tuesday Jul 18 | IntersportsWire

    Digiliti Money and Affymetrix are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitabiliy, institutional ownership and valuation. This is a summary of recent recommendations and price targets for Digiliti Money and Affymetrix, as provided by MarketBeat.com.

    Comment?

  4. Financial Comparison: AffymetrixRead the original story w/Photo

    Thursday Jul 6 | Daily Political

    Affymetrix and Vermillion are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitabiliy, dividends, valuation and institutional ownership. 36.5% of Vermillion shares are owned by institutional investors.

    Comment?

  5. Reviewing AffymetrixRead the original story w/Photo

    Tuesday Jul 4 | IntersportsWire

    Affymetrix and Vermillion are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitabiliy and analyst recommendations. Vermillion has a consensus price target of $2.00, suggesting a potential upside of 6.95%.

    Comment?

  6. Affymetrix (AFFX) Earns Media Impact Score of 0.56Read the original story w/Photo

    Tuesday Jul 4 | IntersportsWire

    News coverage about Affymetrix has been trending very positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time.

    Comment?

  7. Financial Review: Digiliti MoneyRead the original story w/Photo

    Sunday Jul 2 | IntersportsWire

    Affymetrix and DIGILITI MONEY are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitabiliy, risk and valuation. DIGILITI MONEY has a consensus price target of $6.00, indicating a potential upside of 88.68%.

    Comment?

  8. Affymetrix (AFFX) versus Vermillion (VRML) Critical ContrastRead the original story w/Photo

    Saturday Jul 1 | AmericanBankingNews.com

    Affymetrix and Vermillion are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, institutional ownership, profitabiliy, analyst recommendations and dividends. 36.5% of Vermillion shares are held by institutional investors.

    Comment?

  9. Affymetrix (AFFX) Receives Daily Media Impact Score of 0.56Read the original story w/Photo

    Saturday Jun 24 | IntersportsWire

    Media stories about Affymetrix have trended very positive on Saturday, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time.

    Comment?

  10. Digiliti Money (DGLT) and Affymetrix (Affx) Head-To-Head AnalysisRead the original story w/Photo

    Jun 15, 2017 | AmericanBankingNews.com

    DIGILITI MONEY and Affymetrix are both business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitabiliy, earnings, institutional ownership and risk. DIGILITI MONEY presently has a consensus price target of $6.00, indicating a potential upside of 61.73%.

    Comment?

  11. Daniel Collins v. Unum Life Insurance Company of AmericaRead the original story w/Photo

    Mar 9, 2017 | FindLaw

    ... court's decision to uphold the benefits denial and deny Collins additional discovery. Collins was an employee of Affymetrix, Inc. On January 6, 2012, Collins slipped and fell while walking in Affymetrix's parking lot, injuring his foot. His foot was ...

    Comment?

  12. Look For Irhythm Technologies Inc (IRTC) To Groove HigherRead the original story w/Photo

    Nov 9, 2016 | Insider Monkey

    ... in the IT and healthcare industries. Previously, he was a Director, Chief Executive Officer and President of Affymetrix, Inc. (NASDAQ: AFFX ), an innovator of technology in the genetic analysis field. Prior to that, he served as Chief Executive ...

    Comment?

  13. Lion Biotechnologies Appoints Gregory Schiffman as Chief Financial OfficerRead the original story w/Photo

    Oct 3, 2016 | Market Wire

    "As we continue to build the management team into a fully integrated oncology organization, we are delighted to welcome Greg to the team," said Lion Biotechnologies President and CEO, Maria Fardis, Ph.D. "Greg has extensive experience in the cell-based therapy space having overseen finance, accounting and manufacturing functions in his previous positions." Mr. Schiffman brings fifteen years of experience leading the financial operations and strategy of publicly-traded healthcare companies such as Dendreon, Affymetrix and Applied Biosystems.

    Comment?

  14. iRhythm Technologies IPO Could Be HeartwarmingRead the original story w/Photo

    Sep 29, 2016 | Seeking Alpha

    ... Kevin King, who has been with the firm since July 2012 and was previously President of Life Sciences Business at Affymetrix. Mark Day is VP of R&D, also since 2012, and previously worked in the Cardiac Rhythm Disease Management division of medical ...

    Comment?

  15. Great West Life Assurance Co. Can Has $180,000 Position in Affymetrix, Inc.Read the original story w/Photo

    Sep 18, 2016 | Daily Political

    Great West Life Assurance Co. Can maintained its stake in Affymetrix, Inc. during the second quarter, Holdings Channel reports.

    Comment?